Lataa...
Glycan biomarkers for Alzheimer disease correlate with T‐tau and P‐tau in cerebrospinal fluid in subjective cognitive impairment
Alzheimer disease (AD) is a devastating disease and a global health problem, and current treatments are only symptomatic. A wealth of clinical studies support that the disease starts to develop decades before the first symptoms appear, emphasizing the importance of studying early changes for improvi...
Tallennettuna:
| Julkaisussa: | FEBS J |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7496940/ https://ncbi.nlm.nih.gov/pubmed/31889402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/febs.15197 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|